We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Orders Halt to Marketing of Unapproved Gout Drug
FDA Orders Halt to Marketing of Unapproved Gout Drug
October 12, 2010
The FDA is giving manufacturers of unapproved generic versions of oral colchicine 45 days to stop making the gout treatments and 90 days to stop shipping them.